Response to Pak et al, “Regulatory gaps in sunscreen approval: A comparison of U.S. and Korean UV filters.” Sunscreen regulatory update: approval of bemotrizinol by the US FDA
Response to Pak et al, “Regulatory gaps in sunscreen approval: A comparison of U.S. and Korean UV filters.” Sunscreen regulatory update: approval of bemotrizinol by the US FDA. // Journal of the American Academy of Dermatology. – URL: https://www.sciencedirect.com/science/article/pii/S0190962226029993?dgcid=rss_sd_all
Response to Pak et al, “Regulatory gaps in sunscreen approval: A comparison of U.S. and Korean UV filters.” Sunscreen regulatory update: approval of bemotrizinol by the US FDA. Journal of the American Academy of Dermatology. https://www.sciencedirect.com/science/article/pii/S0190962226029993?dgcid=rss_sd_all
“Response to Pak et al, “Regulatory gaps in sunscreen approval: A comparison of U.S. and Korean UV filters.” Sunscreen regulatory update: approval of bemotrizinol by the US FDA.” Journal of the American Academy of Dermatology.
@article{article94483,
title = {Response to Pak et al, “Regulatory gaps in sunscreen approval: A comparison of U.S. and Korean UV filters.” Sunscreen regulatory update: approval of bemotrizinol by the US FDA},
journal = {Journal of the American Academy of Dermatology},
url = {https://www.sciencedirect.com/science/article/pii/S0190962226029993?dgcid=rss_sd_all}
}